These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24887085)

  • 1. Toxic shock syndrome toxin-1-mediated toxicity inhibited by neutralizing antibodies late in the course of continual in vivo and in vitro exposure.
    Stich N; Model N; Samstag A; Gruener CS; Wolf HM; Eibl MM
    Toxins (Basel); 2014 May; 6(6):1724-41. PubMed ID: 24887085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1.
    Rukkawattanakul T; Sookrung N; Seesuay W; Onlamoon N; Diraphat P; Chaicumpa W; Indrawattana N
    Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28218671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcal superantigen (TSST-1) mutant analysis reveals that t cell activation is required for biological effects in the rabbit including the cytokine storm.
    Stich N; Waclavicek M; Model N; Eibl MM
    Toxins (Basel); 2010 Sep; 2(9):2272-88. PubMed ID: 22069685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Titer Persistent Neutralizing Antibodies Induced by TSST-1 Variant Vaccine Against Toxic Shock Cytokine Storm.
    Roetzer A; Stich N; Model N; Schwameis M; Firbas C; Jilma B; Eibl MM
    Toxins (Basel); 2020 Oct; 12(10):. PubMed ID: 33023185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity of lymphocytes activated by superantigen toxic-shock-syndrome toxin-1 against colorectal cancer LoVo cells.
    Wang W; Sun X; Lu L; Zheng JB; Tian Y; Wang W
    Mol Cell Biochem; 2013 Apr; 376(1-2):1-9. PubMed ID: 23340976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial proinflammatory response and curcumin-mediated protection from staphylococcal toxic shock syndrome toxin-1.
    Schaefers MM; Breshears LM; Anderson MJ; Lin YC; Grill AE; Panyam J; Southern PJ; Schlievert PM; Peterson ML
    PLoS One; 2012; 7(3):e32813. PubMed ID: 22431984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig.
    Saha B; Jaklic B; Harlan DM; Gray GS; June CH; Abe R
    J Immunol; 1996 Nov; 157(9):3869-75. PubMed ID: 8892617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic shock syndrome: characterization of human immune responses to TSST-1 and evidence for sensitivity thresholds.
    Kimber I; Nookala S; Davis CC; Gerberick GF; Tucker H; Foertsch LM; Dearman RJ; Parsonnet J; Goering RV; Modern P; Donnellen M; Morel J; Kotb M
    Toxicol Sci; 2013 Jul; 134(1):49-63. PubMed ID: 23640863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression.
    Shaler CR; Choi J; Rudak PT; Memarnejadian A; Szabo PA; Tun-Abraham ME; Rossjohn J; Corbett AJ; McCluskey J; McCormick JK; Lantz O; Hernandez-Alejandro R; Haeryfar SMM
    PLoS Biol; 2017 Jun; 15(6):e2001930. PubMed ID: 28632753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome.
    Bonventre PF; Heeg H; Cullen C; Lian CJ
    Infect Immun; 1993 Mar; 61(3):793-9. PubMed ID: 8432600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
    Arad G; Levy R; Hillman D; Kaempfer R
    Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mutation at histidine residue 135 of toxic shock syndrome toxin yields an immunogenic protein with minimal toxicity.
    Bonventre PF; Heeg H; Edwards CK; Cullen CM
    Infect Immun; 1995 Feb; 63(2):509-15. PubMed ID: 7822015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluid replacement protection of rabbits challenged subcutaneous with toxic shock syndrome toxins.
    Lee PK; Deringer JR; Kreiswirth BN; Novick RP; Schlievert PM
    Infect Immun; 1991 Mar; 59(3):879-84. PubMed ID: 1997438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1.
    Miethke T; Duschek K; Wahl C; Heeg K; Wagner H
    Eur J Immunol; 1993 Jul; 23(7):1494-500. PubMed ID: 8325325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Superantigen Toxic Shock Syndrome Toxin 1 Alters Human Aortic Endothelial Cell Function.
    Kulhankova K; Kinney KJ; Stach JM; Gourronc FA; Grumbach IM; Klingelhutz AJ; Salgado-Pabón W
    Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29229737
    [No Abstract]   [Full Text] [Related]  

  • 16. Engineering a soluble high-affinity receptor domain that neutralizes staphylococcal enterotoxin C in rabbit models of disease.
    Mattis DM; Spaulding AR; Chuang-Smith ON; Sundberg EJ; Schlievert PM; Kranz DM
    Protein Eng Des Sel; 2013 Feb; 26(2):133-42. PubMed ID: 23161916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue Infection.
    Sharma H; Turner CE; Siggins MK; El-Bahrawy M; Pichon B; Kearns A; Sriskandan S
    mSphere; 2019 Oct; 4(5):. PubMed ID: 31597722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific inhibitory action of anisodamine against a staphylococcal superantigenic toxin, toxic shock syndrome toxin 1 (TSST-1), leading to down-regulation of cytokine production and blocking of TSST-1 toxicity in mice.
    Nakagawa S; Kushiya K; Taneike I; Imanishi K; Uchiyama T; Yamamoto T
    Clin Diagn Lab Immunol; 2005 Mar; 12(3):399-408. PubMed ID: 15753253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of recombinant SEA-TSST fusion toxoid for protection against superantigen induced toxicity in mouse model.
    Reddy PN; Paul S; Sripathy MH; Batra HV
    Toxicon; 2015 Sep; 103():106-13. PubMed ID: 26091873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction by toxic-shock-syndrome toxin-1 of a circulating tumor necrosis factor-like substance in rabbits and of immunoreactive tumor necrosis factor and interleukin-1 from human mononuclear cells.
    Ikejima T; Okusawa S; van der Meer JW; Dinarello CA
    J Infect Dis; 1988 Nov; 158(5):1017-25. PubMed ID: 3263446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.